Aprea Therapeutics, Inc. (NASDAQ:APRE) Short Interest Down 34.6% in May

Aprea Therapeutics, Inc. (NASDAQ:APRE – Get Free Report) was the target of a significant decrease in short interest in May. As of May 31st, there was short interest totalling 21,200 shares, a decrease of 34.6% from the May 15th total of 32,400 shares. Based on an average daily trading volume, of 29,200 shares, the days-to-cover […]

Leave a Reply

Your email address will not be published.

Previous post QuantaSing Group Limited (NASDAQ:QSG) Short Interest Update
Next post Adobe (NASDAQ:ADBE) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS